President Donald Trump speaks during a news conference on the North Portico of the White House, Monday, Sept. 7, 2020 (Patrick Semansky/AP Images)
September 8, 2020 06:35 AM EDTUpdated 10:56 AM
Bioregnum
Coronavirus
Opinion

CEOs join reg­u­la­tors and top sci­en­tists vow­ing to hold the line on Covid-19 vac­cine. But will that get in the way of Trump's 'big sur­prise'?

Nine top de­vel­op­ers lead­ing the race to de­vel­op a vac­cine to com­bat Covid-19 are pre­sent­ing a uni­fied front this morn­ing as they joint­ly com­mit …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bio­phar­ma be­gins to con­tem­plate an RFK Jr.-in­flu­enced FDA if Trump wins

Pfiz­er shares new de­tails on obe­si­ty pipeline, hints at ‘oth­er op­por­tu­ni­ties’

GSK buys au­toim­mune T cell en­gager for $300M up­front from Chim­a­gen

No­var­tis takes $800M Mor­phoSys write­down mere months af­ter clos­ing ac­qui­si­tion

No­var­tis high­lights over­all M&A track record fol­low­ing Mor­phoSys im­pair­ment

Fol­low­ing March in­spec­tion, No­vo Nordisk's semaglu­tide man­u­fac­tur­ing fa­cil­i­ty cit­ed by FDA

A service from the Financial Times